Rivaroxaban May Be Clinically Superior to LMWH in Patients With Cancer-Associated Thrombosis
Researchers sought to determine whether rivaroxaban may be superior to low-molecular-weight heparin for reducing all-cause mortality.
Researchers sought to determine whether rivaroxaban may be superior to low-molecular-weight heparin for reducing all-cause mortality.
Results of a phase 3 randomized trial of the eRAPID online system for patients to self-report symptoms while undergoing cancer therapy are presented.
Review highlights current approaches to risk stratification, differential diagnosis, and the optimal use of current treatment options for polycythemia vera.
As the COVID-19 pandemic continues, its toll has extended beyond physical and into the emotional realm. A recent study in JAMA Network Open suggested that the prevalence of depression symptoms in the United States was more than 3 times as great during the presence of COVID-19 as it was prior to the pandemic.¹ Americans are…
Largest decreases seen among high-risk populations, including men, older patients, patients with prostate and lung cancer.
Majority of patients, physicians report satisfaction with virtual care.
A survey of patients with cancer treated in radiation clinics of a major New York metropolitan cancer center reported satisfaction with telemedicine care, compared with in-person visits.
Cancer type, oral health, and frequency of dosing for zoledronic acid linked to risk for osteonecrosis of the jaw.
Experts assessed mortality rates linked to allogeneic stem cell transplantation in the past 40 years using data from the European Society for Blood and Marrow Transplantation registry.
Social shifts related to the COVID-19 pandemic may be uniquely consequential for health behaviors and decisions integral to effective cancer prevention and control.